Abbott Laboratories manufactures medical devices, diagnostic instruments, nutritional products, and pharmaceuticals. Notable offerings include continuous glucose monitoring systems, cardiovascular stents and valves, and infant formula brands. It supplies hospitals, clinics, laboratories, and consumers in over 160 countries with a mix of branded and established products.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 10,358 | — | 1,325 | — |
| Q2 2025 | 11,142 | — | 1,779 | — |
| Q3 2025 | 11,369 | — | 1,644 | — |
| Q4 2025 | 11,459 | — | 1,776 | — |
| Q1 2026 | 11,164 | 7.8% | 1,077 | -18.7% |
All markets — KeepWinning global stock screener
Other companies on NYSE: ConocoPhillips (COP), Deere & Company (DE), McDonald's Corporation (MCD), Union Pacific Corporation (UNP), Novo Nordisk A/S (NVO), Southern Copper Corporation (SCCO)